Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

Axil Capital

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 18
Average round size
info
The average size of a deal this fund participated in
$7M
Portfolio companies 11
Rounds per year 2.57
Lead investments 1
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.28
Exits 2
Key employees 1

Areas of investment

  • Health Care
  • Biotechnology
  • Medical
  • Medical Device
  • Nutrition
Summary

The leading representative office of defined VC is situated in the Tokyo. The company was established in Asia in Japan.

The overall number of key employees were 1.

Among the most popular portfolio startups of the fund, we may highlight Frequency Therapeutics. We can highlight the next thriving fund investment areas, such as Genetics, Medical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States.

The typical case for the fund is to invest in rounds with 4-5 participants. Despite the Axil Capital, startups are often financed by gumi, U.S. Department of Defense, Taiwania Capital. The meaningful sponsors for the fund in investment in the same round are Taiwania Capital, RTW Investments LLC, Polaris Founders Capital. In the next rounds fund is usually obtained by Japan Science and Technology Agency.

The top activity for fund was in 2019. The fund is constantly included in 2-6 deals per year. The increased amount of exits for fund were in 2019. Deals in the range of 10 - 50 millions dollars are the general things for fund.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Axil Capital:
Typical Co-investors
Axil Capital is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Axil Capital:
There are no funds here. If we find new data, we will add it here.

Look at other 50 related and similar funds Collapse list
Fund NameLocation
Activist Artists Management California, United States, West Hollywood
Alliance Capital Arizona, Scottsdale, United States
Alpine Investors California, San Francisco, United States
Amelia Investments -
Bison Capital (China) Beijing, Beijing, China
Chengdu Hi-tech Investment Group -
Garnett & Helfrich Capital California, San Mateo, United States
Hansa Capital Florida, Ponte Vedra Beach, United States
Hastings Equity Partners Massachusetts, Needham, United States
Incept LLC California, Sunnyvale, United States
Jiadel Medical -
OMERS Private Equity Canada, Ontario, Toronto
Ouest Angels Capital France, Nantes, Pays de la Loire
RWE Essen, Germany, Nordrhein-Westfalen
Somerset Capital Colorado, Denver, United States
STS Ventures Cologne, Germany, Nordrhein-Westfalen
Tecton Capital Partners LLC England, London, United Kingdom
Tufts University Massachusetts, Medford, United States
Zigg Capital New York, New York, United States

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

GEXVal

Emergency Medicine
Health Care
$4M04 Dec 2023 Fujisawa, Kanagawa Prefecture, Japan

Cranebio

Health Care
Health Diagnostics
Medical
$2M04 Oct 2023 Tokyo, Kantō, Japan

Cellusion

Biotechnology
Health Care
Medical
$25M07 Jun 2023 Chiyoda, Japan

Suono Bio

Biotechnology
Health Care
Medical
Medical Device
29 Mar 2021 Cambridge, Massachusetts, United States

TechsoMed

Biotechnology
Health Care
$7M03 Mar 2021 Israel, Tel Aviv District, Israel

LUCA Science

Biotechnology
Health Care
Pharmaceutical
$9M01 Sep 2020 Chiyoda

JOLLY GOOD

Computer
Internet
Software
$910K25 Jul 2019 Chiyoda, Japan

Frequency Therapeutics

Biotechnology
Genetics
Medical
$62M23 Jul 2019 Woburn, Massachusetts, United States

United Immunity

Health Care
Nursing and Residential Care
Nutrition
07 Jun 2019 Osaka, Osaka Prefecture, Japan
News
Suono Bio Raises $8.5M in Series A Funding

– Suono Bio, Inc. is a biotech company based in Foxborough, Massachusetts.
– The company raised $8.5m in Series A funding.
– The round was led by Axil Capital and Mizuho Securities Principal Investment with participation from Taiwania Capital and other investors.
– The new funding will be used to advance its lead programs in inflammatory bowel disease as well as expansion of its pipeline.

Suono Bio, Inc. Announces Oversubscribed Series A Funding Round Led by Axil Capital and Mizuho Securities Principal Investment

– Suono Bio, Inc. has raised an $8.5m Series A financing led by Axil Capital and Mizuho Securities Principal Investment, with participation by Taiwania Capital and other investors.
– Suono Bio will utilize the funds to advance its lead programs in inflammatory bowel disease as well as expansion of its pipeline.
– The company leverages technology developed in the laboratory of Institute Professor Robert Langer at the Massachusetts Institute of Technology (MIT) to facilitate rapid, local administration of therapeutics to treat serious diseases.
– The company was founded by Professor Langer, Professor Giovanni Traverso, from the Department of Mechanical Engineering at MIT and a gastroenterologist and biomedical engineer at Brigham and Women’s Hospital, Harvard Medical School, and Dr. Carl Schoellhammer.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Axil Capital?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 18
Average round size 7M
Rounds per year 2.57
Peak activity year 2019
Lead investments 1
Follow on index 0.28
Exits 2
Group Appearance index 0.89

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

GEXVal

Emergency Medicine
Health Care
$4M04 Dec 2023 Fujisawa, Kanagawa Prefecture, Japan

Cranebio

Health Care
Health Diagnostics
Medical
$2M04 Oct 2023 Tokyo, Kantō, Japan

Cellusion

Biotechnology
Health Care
Medical
$25M07 Jun 2023 Chiyoda, Japan

Suono Bio

Biotechnology
Health Care
Medical
Medical Device
29 Mar 2021 Cambridge, Massachusetts, United States

TechsoMed

Biotechnology
Health Care
$7M03 Mar 2021 Israel, Tel Aviv District, Israel

LUCA Science

Biotechnology
Health Care
Pharmaceutical
$9M01 Sep 2020 Chiyoda

JOLLY GOOD

Computer
Internet
Software
$910K25 Jul 2019 Chiyoda, Japan

Frequency Therapeutics

Biotechnology
Genetics
Medical
$62M23 Jul 2019 Woburn, Massachusetts, United States

United Immunity

Health Care
Nursing and Residential Care
Nutrition
07 Jun 2019 Osaka, Osaka Prefecture, Japan
Crunchbase icon

Content report

The following text will be sent to our editors: